News Conference News EuroPCR 2024 ORBITA-2: Angina Phenotype Strongly Predicts PCI Response Caitlin E. Cox May 15, 2024
News Conference News EuroPCR 2023 AnchorMan LAAO Device Matches Up Well With the Watchman Todd Neale May 19, 2023
News Conference News EuroPCR 2022 Self-Expanding TAVI Valves Offer Best Results in Small Failed Aortic Bioprostheses: LYTEN Caitlin E. Cox May 27, 2022
News Conference News EuroPCR 2022 Changes in Cardiac Damage After AVR Tied to 2-Year Outcomes Caitlin E. Cox May 17, 2022
News Conference News EuroPCR 2020 Novel Ultrasound Therapy Shows Promise for Patients Unfit for TAVR, SAVR L.A. McKeown July 01, 2020
News Conference News EuroPCR 2019 TAVR Durability ‘Snapshot’ Offers Some Reassurances 8 to 10 Years Out Caitlin E. Cox May 24, 2019
News Conference News EuroPCR 2018 ORBITA Deep Dive Highlights Treatment Choices, Social Media, and Ethics Michael O'Riordan May 31, 2018
News Conference News EuroPCR 2018 Pace Quickens for Mitral Device Innovation for Repair, Replacement Yael L. Maxwell May 24, 2018
News Conference News EuroPCR 2018 NOTION: TAVR in Low-Risk Patients Maintains Its Momentum Through 6 Years Caitlin E. Cox May 24, 2018
News Conference News EuroPCR 2018 New ORBITA Insights: Invasive Physiology Tests Track Closely With Ischemia, but Not Symptom Improvement Shelley Wood May 22, 2018
News Conference News EuroPCR 2018 Big Data, Big Questions: Physicians and Innovators Consider AI’s Role in Clinical Care Michael O'Riordan May 21, 2018
News Conference News EuroPCR 2014 Benefit of LAA Closure Becomes Most Evident After 1 Year Caitlin E. Cox May 23, 2014
News Conference News EuroPCR 2013 Deflection Device Reduces Volume, Not Number, of Cerebral Lesions During TAVR Jason Kahn May 24, 2013
News Conference News EuroPCR 2012 Global Valve-in-Valve Registry: Procedure Technically Challenging, but Highly Feasible Caitlin E. Cox May 16, 2012